A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)

BACKGROUND: The optimal treatment of BRCA wild-type patients with platinum-sensitive recurrent ovarian cancer remains unknown. Recently, there is an increase in the evidence to support the role of the combination of a poly(adenosine diphosphate-ribose) polymerase inhibitor, anti-angiogenic agents, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gynecol Oncol
Main Authors: Lee, Yong Jae, Lim, Myong Cheol, Kim, Byoung-Gie, Ngoi, Natalie YL, Choi, Chel Hun, Park, Sang-Yoon, Tan, David SP, Go, Yunjung, Lee, Jung-Yun
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Assuntos:
Clinical Trial Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930449/
https://ncbi.nlm.nih.gov/pubmed/33559413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e31
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados